- Q1 19 %38,8
- Q2 13 %26,5
- Q3 14 %28,6
- Q4 3 %6,1
Akademisyen
EMRE KARA
DOKTOR ÖĞRETİM ÜYESİ
Araştırma konuları OpenAlex
- Pharmaceutical Practices and Patient Outcomes10
- Antibiotic Use and Resistance10
- Antibiotics Pharmacokinetics and Efficacy9
- Antifungal resistance and susceptibility8
- Pneumonia and Respiratory Infections4
- Pneumocystis jirovecii pneumonia detection and treatment4
- Antibiotic Resistance in Bacteria4
- HIV-related health complications and treatments4
- Medication Adherence and Compliance4
- Antimicrobial Resistance in Staphylococcus4
- Mobile Health and mHealth Applications4
- COVID-19 Clinical Research Studies3
Akademik özet
YÖKSİS ve OpenAlex ayrı sayılır.
Makale
65
YÖKSİS65
OpenAlex0
Proje
2
Kitap
10
Bildiri
42
Atıf etkisi
OpenAlex YÖKSİS makalelerinden OpenAlex’te eşleşen: 54
h-indeks
8
Türkiye yüzdelik dilimi: 78
Üniversitesinde h-indekse göre 853. / 2.315
- i10-indeks
- 7
- Toplam atıf
- 256 Türkiye’de üst %20
- Makale başına
- 4,7
- FWCI
- 0,88 1,00 = dünya ortalaması
- Dünyada üst %1
- 0
- Dünyada üst %10
- 4
En çok atıf alan makaleleri
h-indeks ve atıflar, bu akademisyenin YÖKSİS makalelerinden OpenAlex’te eşleşenlerin atıf sayılarından hesaplanır (Google Scholar, WoS veya Scopus değildir). Eşleşmeyen makalelerin atıfı dahil değildir.
Alan sıralaması
YÖKSİS ?-
Ana dal Sağlık Bilimleri Temel AlanıPuan sırası #33.997/ 43.834 üst %77,6 Üniversitede #908/ 1.066Puan 0 dergi 0 · OA ek 0
- Makale sırası33.997/43.834
- Scopus sırası33.842/43.834
- WoS sırası33.827/43.834
- YÖKSİS0
- Scopus0
- WoS0
-
Yan dal Klinik EczacılıkPuan sırası #66/ 89 üst %74,2 Üniversitede #10/ 10Puan 0 dergi 0 · OA ek 0
- Makale sırası66/89
- Scopus sırası66/89
- WoS sırası66/89
- YÖKSİS0
- Scopus0
- WoS0
Dizin çeyrekleri
?- Q1 15 %26,8
- Q2 13 %23,2
- Q3 9 %16,1
- Q4 19 %33,9
Üst %10
Üst %106
Ort. · n 57
%53,6
Diğer sayımlar
Scopus (SJR)
- YÖKSİS satırı 53
WoS (JCR)
- YÖKSİS satırı 60
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Yayını olan dergiler
36 dergi
- ISSN 1300-932X 10
- International Journal of Antimicrobial Agents 7
- Turkish Journal of Pharmaceutical Sciences 4
- Postgraduate Medicine 3
- Turkish Journal of Medical Sciences 3
- Antimicrobial Agents and Chemotherapy 2
- British Journal of Clinical Pharmacology 2
- European Journal of Hospital Pharmacy 2
- International Journal of Clinical Practice 2
- Journal of Investigative Medicine 2
- Mediterranean Journal of Infection, Microbes and Antimicrobials 2
- ISSN 1300-0853 1
- ISSN 2146-944X 1
- ISSN 2146-9660 1
- ISSN 2147-9488 1
- ISSN 2630-5569 1
- American Journal of Emergency Medicine 1
- BMC Medical Education 1
- Critical Care 1
- European Journal of Clinical Microbiology and Infectious Diseases 1
- Fabad Journal of Pharmaceutical Sciences 1
- Indian Journal of Hematology and Blood Transfusion 1
- International Journal of Clinical Pharmacy 1
- Irish Journal of Medical Science 1
- Journal of Infection in Developing Countries 1
- Journal of Inonu University Vocational School of Health Services 1
- Journal of Medical and Surgical Intensive Care Medicine 1
- Journal of Research in Pharmacy 1
- Medical Mycology 1
- Medical Principles and Practice 1
- Primary Health Care Research and Development 1
- Research in Social and Administrative Pharmacy 1
- Therapeutic Apheresis and Dialysis 1
- Thrombosis Research 1
- Transplant Infectious Disease 1
- Turkish Journal of Pediatrics 1
Daralt
Makale listesi
- 2026 Posaconazole Therapeutic Drug Monitoring in Daily Practice: A Single-Center Analysis YÖKSİS SJR Q3 JCR Q4 OpenAlex 17.8%
- 2025 Impact of pharmacist-led interventions on economic, clinical, and humanistic outcomes (ECHO) in patients admitted to emergency departments: A systematic review of randomized controlled trials YÖKSİS SJR Q1 JCR Q1 OpenAlex 33.6%
- 2025 Inhaled Aviptadil Is a New Hope for Recovery of Lung Damage due to COVID-19 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 94.9%
- 2025 In reply to the letter to the editor regarding ‘Battle of polymyxin induced nephrotoxicity: Polymyxin B versus colistin’ YÖKSİS SJR Q1 JCR Q1
- 2025 Turkish translation and cultural adaptation of the Ascertaining Barriers to Compliance taxonomy for medication adherence YÖKSİS SJR Q1 JCR Q2 OpenAlex 70.6%
- 2025 The impact of the COVID-19 on the antifungal consumption and antifungal resistance in Candida species isolated from the blood cultures of critically ill patients in intensive care units YÖKSİS SJR Q1 JCR Q1 OpenAlex 82.6%
- 2025 Comparison of piperacillin-tazobactam and vancomycin (TZP-VAN) with piperacillin-tazobactam and teicoplanin (TZP-TEI) for the risk of acute kidney injury (CONCOMITANT): A prospective observational, multinational, multi-centre cohort study YÖKSİS SJR Q1 JCR Q1 OpenAlex 86.3%
- 2025 Therapeutic drug monitoring in patients treated with vancomycin: a single center, prospective, observational, real-world study YÖKSİS SJR Q1 JCR Q2 OpenAlex 80.6%
- 2025 Intentions of hospital pharmacists to use digital technology in their daily practice: a cross-sectional survey using the Theory of Planned Behaviour YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 97.8%
- 2025 Hekim ve Eczacıların Farmakovijilans Hakkında Bilgi, Tutum ve Davranışlarının Değerlendirilmesi: Kesitsel Araştırma YÖKSİS
- 2025 Stenotrophomonas maltophilia Kaynaklı İnfeksiyonların Tedavisi: Geleneksel Bir Derleme YÖKSİS TR Index JCR Q4 OpenAlex 3.8%
- 2024 Examination of drug removal profiles in patients undergoing therapeutic plasma exchange: A retrospective study YÖKSİS SJR Q3 JCR Q3 OpenAlex 14.6%
- 2024 Monitoring of the cerebrospinal fluid voriconazole level in a patient with recurrent Candida meningitis after pituitary surgery YÖKSİS SJR Q1 JCR Q1 OpenAlex 57.4%
- 2024 Compliance with guideline recommendations in the management of patients with hospitalized community-acquired pneumonia YÖKSİS SJR Q2 JCR Q2 OpenAlex 63.2%
- 2024 Antimicrobial management in patients undergoing therapeutic plasma exchange: A Cross-Sectional Nationwide Survey YÖKSİS SJR Q2 JCR Q2 OpenAlex 17.4%
- 2024 Effect of inflammation on voriconazole levels in patients with invasive pulmonary aspergillosis YÖKSİS SJR Q3 JCR Q4 OpenAlex 22.7%
- 2024 Effect of therapeutic plasma exchange on antimicrobials in critically ill patients YÖKSİS SJR Q1 JCR Q1 OpenAlex 78.2%
- 2024 Beyond conventional dosing: tailoring antimicrobial regimens for cachexia YÖKSİS SJR Q2 JCR Q4 OpenAlex 52.9%
- 2024 Tigecycline-associated hypofibrinogenemia: A single center, retrospective, controlled study YÖKSİS SJR Q2 JCR Q2 OpenAlex 79.5%
- 2024 Evaluation of infectious diseases physicians’ attitudes to dyslipidemia management in PLWH YÖKSİS SJR Q2 JCR Q1 OpenAlex 68.7%